Reading Hospital, Reading.
Division of Rheumatology, University of Pennsylvania, Philadelphia, USA.
Curr Opin Rheumatol. 2018 Nov;30(6):588-593. doi: 10.1097/BOR.0000000000000551.
Systemic sclerosis is a debilitating rheumatic disease with high morbidity and mortality. This review attempts to provide the most recent update on mortality and survival and their determinants in systemic sclerosis (SSc).
SSc remains an uncommon rheumatic disease with high mortality. There have been attempts to devise more comprehensive but simpler scoring systems to prognosticate survival in SSc, which will influence triaging of patients and guide the utilization of aggressive treatment strategies.
Updated literature review on mortality and survival in SSc has confirmed its high-case fatality but a slowly improving survival profile over time. It identifies some gaps in knowledge, especially in regards to ethnic differences.
系统性硬化症是一种使人虚弱的风湿性疾病,发病率和死亡率都很高。本综述试图提供系统性硬化症(SSc)死亡率和生存率及其决定因素的最新更新。
SSc 仍然是一种罕见的风湿性疾病,死亡率很高。人们试图设计更全面但更简单的评分系统来预测 SSc 的生存率,这将影响患者的分诊,并指导积极的治疗策略的应用。
对 SSc 死亡率和生存率的最新文献综述证实了其高病死率,但随着时间的推移,生存率的情况正在缓慢改善。它还确定了一些知识上的差距,特别是在种族差异方面。